These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 16280352)

  • 1. Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88).
    Hobart JC; Riazi A; Thompson AJ; Styles IM; Ingram W; Vickery PJ; Warner M; Fox PJ; Zajicek JP
    Brain; 2006 Jan; 129(Pt 1):224-34. PubMed ID: 16280352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 88-item Multiple Sclerosis Spasticity Scale: a Rasch validation of the Italian version and suggestions for refinement of the original scale.
    Pellicciari L; Ottonello M; Giordano A; Albensi C; Franchignoni F
    Qual Life Res; 2019 Jan; 28(1):221-231. PubMed ID: 30238266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure.
    Hobart J; Lamping D; Fitzpatrick R; Riazi A; Thompson A
    Brain; 2001 May; 124(Pt 5):962-73. PubMed ID: 11335698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome.
    Hobart JC; Riazi A; Lamping DL; Fitzpatrick R; Thompson AJ
    Health Technol Assess; 2004 Mar; 8(9):iii, 1-48. PubMed ID: 14982653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cross-cultural adaptation and psychometric validation of the MSSS-88 for use in Italian patients with multiple sclerosis.
    Ottonello M; Pellicciari L; Centonze D; Foti C; Pistarini C; Albensi C; Giordano A
    Disabil Rehabil; 2019 Feb; 41(4):465-471. PubMed ID: 29069950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Serbian Version of Multiple Sclerosis Spasticity Scale 88 (MSSS-88).
    Rodic SZ; Knezevic TI; Kisic-Tepavcevic DB; Dackovic JR; Dujmovic I; Pekmezovic TD; Drulovic JS; Konstantinovic LM
    PLoS One; 2016; 11(1):e0147042. PubMed ID: 26771661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Multiple Sclerosis Spasticity Scale 88: A Short Report.
    Freeman J; Gorst T; Ofori J; Marsden J
    Rehabil Process Outcome; 2019; 8():1179572718823510. PubMed ID: 34497457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods.
    Hobart J; Cano S
    Health Technol Assess; 2009 Feb; 13(12):iii, ix-x, 1-177. PubMed ID: 19216837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can the ABILHAND handle manual ability in MS?
    Barrett LE; Cano SJ; Zajicek JP; Hobart JC
    Mult Scler; 2013 May; 19(6):806-15. PubMed ID: 23095289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12).
    Hobart JC; Riazi A; Lamping DL; Fitzpatrick R; Thompson AJ
    Neurology; 2003 Jan; 60(1):31-6. PubMed ID: 12525714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rasch measurement: the Arm Activity measure (ArmA) passive function sub-scale.
    Ashford S; Siegert RJ; Alexandrescu R
    Disabil Rehabil; 2016; 38(4):384-90. PubMed ID: 25918961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linguistic and psychometric validation of the MSSS-88 questionnaire for patients with multiple sclerosis and spasticity in Germany.
    Henze T; von Mackensen S; Lehrieder G; Zettl UK; Pfiffner C; Flachenecker P
    Health Qual Life Outcomes; 2014 Aug; 12():119. PubMed ID: 25080934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The meaning of spasticity to people with multiple sclerosis: what can health professionals learn?
    Morley A; Tod A; Cramp M; Mawson S
    Disabil Rehabil; 2013 Jul; 35(15):1284-92. PubMed ID: 23373525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of the functional vision questionnaire for children and young people with visual impairment: the FVQ_CYP.
    Tadić V; Cooper A; Cumberland P; Lewando-Hundt G; Rahi JS;
    Ophthalmology; 2013 Dec; 120(12):2725-2732. PubMed ID: 24120327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SF-36 in multiple sclerosis: why basic assumptions must be tested.
    Hobart J; Freeman J; Lamping D; Fitzpatrick R; Thompson A
    J Neurol Neurosurg Psychiatry; 2001 Sep; 71(3):363-70. PubMed ID: 11511712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using existing data to identify candidate items for a health state classification system in multiple sclerosis.
    Kuspinar A; Finch L; Pickard S; Mayo NE
    Qual Life Res; 2014 Jun; 23(5):1445-57. PubMed ID: 24338161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond the reach of traditional analyses: using Rasch to evaluate the DASH in people with multiple sclerosis.
    Cano SJ; Barrett LE; Zajicek JP; Hobart JC
    Mult Scler; 2011 Feb; 17(2):214-22. PubMed ID: 20947530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing a disease-specific quality of life measure for people with multiple sclerosis.
    Ford HL; Gerry E; Tennant A; Whalley D; Haigh R; Johnson MH
    Clin Rehabil; 2001 Jun; 15(3):247-58. PubMed ID: 11386394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Achieving valid patient-reported outcomes measurement: a lesson from fatigue in multiple sclerosis.
    Hobart J; Cano S; Baron R; Thompson A; Schwid S; Zajicek J; Andrich D
    Mult Scler; 2013 Nov; 19(13):1773-83. PubMed ID: 23574800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a self-report physical function instrument for disability assessment: item pool construction and factor analysis.
    McDonough CM; Jette AM; Ni P; Bogusz K; Marfeo EE; Brandt DE; Chan L; Meterko M; Haley SM; Rasch EK
    Arch Phys Med Rehabil; 2013 Sep; 94(9):1653-60. PubMed ID: 23542402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.